Boombostic Health

Bradley Bostic

Welcome to Boombostic Health, where we challenge the business of healthcare and explore bold ideas that drive meaningful change. Each week we bring you candid conversations with top experts, innovators and leaders exploring the latest trends and technologies shaping the future of healthcare.

  1. Diagnostics at the Center: Turning Real-World Data Into Better Care

    3D AGO

    Diagnostics at the Center: Turning Real-World Data Into Better Care

    Diagnostics are no longer just about confirming what is wrong. They are becoming one of the most powerful tools for predicting what comes next. In this episode of Boombostic Health, Bradley Bostic leads a timely conversation with healthcare and diagnostics leaders on how real-world patient data, genomics, AI, and embedded research models are changing the way healthcare systems identify risk, close care gaps, and deliver more personalized care. The discussion moves beyond the promise of innovation and into the practical realities of adoption. How do we turn routine care into continuous learning? How do we prove the value of advanced diagnostics to payers? How do we expand access without creating new forms of bias? And how do we help patients and providers trust the data, the science, and the recommendations that follow? From home-based testing and consumer-driven care to reimbursement, incidental findings, data diversity, and health economics, this episode explores what it will take to move diagnostics from the edge of healthcare innovation into the center of everyday clinical decision-making. What You'll Learn How diagnostics are shifting from episodic testing to continuous healthcare intelligence Why real-world data is essential to predicting outcomes and improving care pathways How genomics and AI can support more personalized, proactive care What it takes to build the business case for diagnostic innovation Why reimbursement models must evolve to keep pace with scientific progress How embedded research can make routine care more evidence-driven Why patient trust, education, and transparency are critical to adoption How data diversity can help reduce bias and improve care for underserved populations Why This Conversation Matters Healthcare does not have a data shortage. It has an actionability problem. The future of diagnostics will depend on the ability to connect data to decisions, research to routine care, and innovation to measurable impact. This conversation makes the case for diagnostics as a strategic foundation for better care, smarter economics, and more equitable outcomes. Key Moments 00:00 — Why diagnostics are becoming central to healthcare innovation 02:38 — Embedding research into routine care 04:17 — Using data to predict health outcomes 06:10 — Making the case for payer coverage and cost savings 09:58 — Bringing diagnostic models into clinical workflows 11:14 — The rise of home-based and consumer-driven testing 14:23 — Managing incidental findings responsibly 17:34 — Connecting diagnostics to health economics 24:07 — Addressing disparities, access, and data bias 27:33 — Moving from research to routine clinical care 32:39 — Empowering patients through health technology Featured Topics Real-world evidence Personalized medicine Genomics and AI Diagnostic innovation At-home testing Reimbursement and payer coverage Health economics Data diversity and bias Patient engagement Clinical workflow integration Resources hc1  uMed  Simple HealthKit Closing Thought The next era of healthcare will not be defined by more testing alone. It will be defined by whether diagnostics can help turn real-world data into earlier action, better decisions, and measurable improvements in care.

    34 min
  2. The Hospital Room That Watches Over Patients (Without Replacing Nurses)

    MAY 12

    The Hospital Room That Watches Over Patients (Without Replacing Nurses)

    The hospital room is becoming intelligent. In this episode of Boombostic Health, Bradley Bostic sits down with Adam McMullin, CEO of AvaSure, to discuss how AI-enabled virtual care is helping health systems improve patient safety, support nurses, and extend clinical capacity without losing the human touch. AvaSure pioneered virtual safety and is now helping hospitals move beyond pilots into scalable, ROI-driven care transformation. Adam shares how intelligent room technology, computer vision, virtual nursing, and open platform integrations are changing what care teams can see, how quickly they can act, and where scarce clinical resources can be used most effectively. The conversation gets into the real pressures facing health systems today: patient falls, ED boarding, documentation burden, specialty access, workforce shortages, and the rising issue of violence against care teams. This is not a conversation about AI replacing clinicians. It is about using AI and virtual care infrastructure to give clinicians better visibility, better support, and more time with patients. Key Topics Virtual safety and the future of patient observation How intelligent rooms can reduce risk and improve workflow Why hard-dollar ROI matters for scaling healthcare technology The role of AI, computer vision, and virtual nursing in care delivery How AvaSure is helping health systems bring more human connection back into care Key Takeaway The future of hospital innovation is not more disconnected technology. It is intelligent infrastructure that helps care teams act sooner, work smarter, and care better.

    35 min
  3. AI Is Rewriting Diagnostics - Here's What's Coming Next

    MAY 5

    AI Is Rewriting Diagnostics - Here's What's Coming Next

    Transforming Diagnostics: Unlocking Value in the Future of Healthcare In this episode of Boombostic Health, Bradley Bostic sits down with Robert Michel, founder of Executive War College and editor-in-chief of The Dark Report, for a wide-ranging conversation on the past, present, and future of laboratory diagnostics. From the origin story behind Executive War College to the rise of genomics, AI, remote monitoring, and personalized medicine, Robert shares why diagnostics are far more than a line item in healthcare spending. They are one of the most powerful levers for improving outcomes, reducing cost, and helping health systems act earlier. The conversation explores how lab data can move from being underused information to a strategic asset that supports better decisions across maternal health, chronic disease, medication optimization, aging in place, and preventive care. In this episode Bradley and Robert discuss: Why the name Executive War College reflects the strategic decisions lab leaders face How genomics has evolved from early PCR testing to affordable whole-genome sequencing Why diagnostics are central to early detection, patient monitoring, and better outcomes How proactive lab-driven interventions can reduce avoidable healthcare costs Why lab services are often viewed as a cost center despite their impact on total medical spend How labs can become strategic partners by turning data into actionable insight The role AI may play in faster, more precise diagnostic decision-making How wearables, remote monitoring, robotics, and personalized health data could reshape care Why nutrition, microbiome, lifestyle, and prevention are becoming harder to separate from healthcare What longevity research and Blue Zones can teach us about healthspan Why early adopters and innovation communities matter in advancing healthcare transformation Key takeaways Diagnostics are no longer just about test results. They are becoming a strategic intelligence layer for healthcare. Lab data has the potential to help health systems identify risk earlier, intervene sooner, and reduce avoidable cost. The future of healthcare will be shaped by the convergence of diagnostics, AI, remote monitoring, personalized medicine, and more proactive care models. Timestamps 00:00 — Why "Executive War College" became the name and what it signals about lab leadership 02:09 — The evolution of genomics technology since 1995 04:49 — From genetic research to practical diagnostic applications 06:14 — Unlocking the value of lab data for outcomes and cost savings 09:57 — How proactive lab testing can improve maternal and neonatal health 12:56 — Addressing anemia, medication optimization, and other preventable gaps 16:54 — The future of diagnostics, AI, and rapid medical insight 17:43 — Biometric wearables, holistic health, and extending healthspan 20:08 — Nutrition, microbiome, and the shift toward preventive care 25:38 — Lessons from Blue Zones on diet, longevity, and lifestyle 27:24 — Robotics, AI, and aging-in-place care models 32:02 — The future of pharmaceuticals, longevity, and space-age innovation 33:08 — Why innovation communities and early adopters drive progress

    35 min
  4. The Test That Could Catch Pancreatic Cancer Before It's Deadly

    APR 21

    The Test That Could Catch Pancreatic Cancer Before It's Deadly

    Are we really close to catching pancreatic cancer early? This silent killer still kills 75% within the first year of diagnosis. But what if we could spot clues before it becomes deadly? Transforming Pancreatic Cancer Detection with Amplified SciencesIn this episode, Bradley Bostic hosts Diana Caldwell, CEO and co-founder of Amplified Sciences, to explore groundbreaking advancements in early detection of pancreatic cancer. Given the devastating prognosis of late-stage diagnosis, their discussion highlights how innovative diagnostics can shift the paradigm towards earlier, less invasive screening—saving lives and improving outcomes.Main insights: The dire statistics of pancreatic cancer survival rates highlight an urgent need for better screening. Amplified Sciences has developed a multi-omics approach that detects precancerous cysts, much like colon polyps, allowing preemptive intervention. The current standard, often reactive, diagnosis leads to late-stage detection; the new method aims to identify risks before symptoms appear. They discuss the importance of high negative predictive value (NPV) to rule out malignancy non-invasively. The platform uses minimal cyst fluid — only 10 times less than existing tests — crucial for small lesions. The approach combines various biomarkers (proteomic, enzymatic, genetic) to improve accuracy. Blood-based screening for early detection remains challenging, but amplification of fluid samples offers more precise insights. Regulatory milestones, like CAP accreditation, position Amplified Sciences for wider clinical adoption. Payer and coverage discussions are ongoing but vital for making this technology accessible. The episode emphasizes how technological innovation, multidisciplinary collaboration, and early detection can revolutionize pancreatic cancer care. Timestamps: 00:11 - Introduction and personal story highlighting the importance of early cancer detection 01:08 - Diana Caldwell's background and motivation to improve gastroenterology diagnostics 04:38 - The science behind Amplified Sciences' diagnostic platform and research origins 07:27 - Current challenges in pancreatic cancer diagnosis and the limitations of standard tests 09:18 - Understanding the brutal statistics and silent progression of pancreatic cancer 10:12 - How genetic factors and incidental screening can identify high-risk individuals 12:41 - The patient journey: from incidental detection to invasive procedures and unmet needs 14:15 - The role of the PANSIS Pro test, regulatory milestones, and sample requirements 16:03 - Differentiating between benign cysts and pre-malignant lesions like IPMN 17:24 - The significance of multi-omic diagnostics and reducing unnecessary surgeries 21:18 - Screening strategies: incidentally detected lesions and the importance of size and location 24:04 - Limitations of current biomarkers like CA 19-9 and the promise of multi-marker panels 26:02 - The unique approach of liquid-focused diagnostics versus traditional blood tests 29:18 - Reimbursement hurdles and the importance of demonstrating clinical utility 32:13 - The mental health impact of uncertain diagnoses and proactive testing benefits 33:55 - The vision for a future where early detection becomes routine and standard careResources & Links: Resources & Links: Amplified Sciences Official Website: https://amplifiedsciences.com/ Connect with Diana Caldwell on LinkedIn: https://www.linkedin.com/in/dianathompsoncaldwell/ This episode underscores the power of innovative diagnostics to intercept pancreatic cancer early, transforming a deadly prognosis into manageable health outcomes. It highlights the collaborative effort needed across research, regulation, and healthcare platforms to ensure these breakthroughs reach patients.

    38 min
  5. Healthcare is still broken

    APR 14

    Healthcare is still broken

    How Health Gorilla is Transforming Healthcare Data Interoperability This episode dives into the story of Health Gorilla and its founder, Bob Watson, revealing how innovative approaches are tackling one of healthcare's most persistent problems: data interoperability. With decades of experience, Bob shares strategic insights and the evolving landscape that is shaping the future of healthcare information exchange.In this episode: Bob Watson's background at Cerner and lessons from early interoperability efforts The evolution of data blocking strategies and shifting industry tactics How TEFCA's implementation is creating new momentum for healthcare data sharing The core value propositions behind Health Gorilla's platform The importance of high-quality, AI-ready healthcare data Challenges and opportunities in integrating medical images into electronic sharing How legacy systems are connected through Health Gorilla's architecture The role of government regulation and penalties in driving compliance The vision for a future where healthcare data is seamless, actionable, and patient-centric Timestamps:00:00 - Introduction to Bob Watson and the origins of Health Gorilla 00:08 - Bob's experience at Cerner and pioneering early health IT initiatives 00:32 - Building the Connected Community and lessons from early EHR adoption 00:58 - Data blocking strategies in the 90s and their impact on interoperability 01:44 - Bob's transition to turnaround leadership and lessons from multiple engagements 02:15 - The importance of the right team and strategic focus for tech companies 02:28 - Narrowing down core customer profiles and target markets 02:43 - Focus on Epic, Cerner, and e-clinical work as key interoperable systems 03:07 - Value-based care and the role of data in Medicare Advantage programs 03:26 - Developing private lab networks and new use cases under TEFCA 03:52 - How TEFCA's implementation increases data exchange traffic 04:21 - Facilitating patient data access and reciprocity in information sharing 04:48 - Industry impact of data blocking lawsuits and regulatory changes 05:13 - The federal push for interoperability akin to the HITECH Act 05:39 - Penalties and non-compliance consequences as enforcement tools 06:01 - Delivering high-quality, actionable data for AI and clinical decision-making 06:23 - Personal story: navigating healthcare data transfer challenges as a patient 06:45 - The future of incentivizing interoperability through economic measures 07:07 - Infrastructure at the endpoints vs. legacy system dependencies 07:25 - Delivering consumable, easy-to-interpret data for busy clinicians 07:53 - Reducing care gaps through comprehensive, uniform health records 08:18 - The importance of high-certainty data for AI training and predictive care 09:02 - How Health Gorilla's curated, accurate data supports advanced AI applications 09:41 - Bob's return from retired life to address relentless interoperability challenges 10:26 - The evolving role of images and challenges in flowing medical imaging data 11:11 - Vendor issues and technical constraints in transmitting medical images 11:27 - The goal to improve data quality and flow from legacy systems like Meditech 11:51 - Connecting all legacy networks for comprehensive data sharing 12:05 - The potential for Health Gorilla to be a significant player in healthcare interoperability 12:29 - The importance of government support—sticks and carrots—in fostering industry change 12:42 - Closing thoughts: the future of seamless, actionable healthcare data

    13 min
  6. Why Diagnostics Will Power the Future of Care

    APR 8

    Why Diagnostics Will Power the Future of Care

    Insights from Eric Strafel of Molecular Testing LabsDiscover how industry veterans are reshaping healthcare through innovative diagnostics, integrating systems thinking, and leveraging AI. In this episode, Eric Strafel discusses the intersection of aerospace principles with healthcare, the future of home testing, and the power of diagnostics as the healthcare data engine. Key Topics: Transition from aerospace innovation to healthcare diagnostics and systems thinking The balance between structured processes and innovation in lab operations How program management practices from defense are transforming healthcare workflows The role of diagnostics in unlocking personalized, data-driven care Impact and evolution of home testing post-pandemic Bridging consumer health and traditional care with digital health tools AI's role in automating workflows and enhancing patient engagement The future of diagnostics as the foundational infrastructure of healthcare Leadership strategies for agility, innovation, and scaling in healthcare labs The importance of early diagnostic engagement for healthy aging Timestamps: 00:00 - Introduction to Eric Strafel and his transition from aerospace to healthcare diagnostics 02:24 - The importance of systems thinking and process robustness from aerospace in healthcare 03:17 - Impact of program management practices in healthcare labs 04:37 - The role of diagnostics in addressing barriers to testing and care engagement 05:24 - The evolution and future of home testing post-pandemic 07:15 - The integration of consumer-centered health and traditional care through digital tools 07:35 - How AI automates lab workflows and improves capacity 09:06 - The vision of diagnostics as the data engine powering personalized healthcare 10:24 - The critical role of diagnostics in the future of healthcare data ecosystems 11:13 - The importance of early diagnostics for healthy aging 12:11 - Leaders' focus on innovation, agility, and scaling in the diagnostic industry Resources & Links: Molecular Testing Labs Eric Strafel LinkedIn

    14 min
  7. BROKEN ACCESS: 40% CAN'T REACH CARE

    MAR 26

    BROKEN ACCESS: 40% CAN'T REACH CARE

    Transforming Healthcare Access with Simple Health Kit and Mark Cuban Partnership Discover how Dr. Sheena Menezes and Simple Health Kit are revolutionizing healthcare through community-centered platforms, innovative lab kits, and a strategic partnership with Mark Cuban's Cosplus Pharmacy. This episode details the vision for equitable access and the integration of technology in healthcare. In this episode:  The foundation and mission of Simple Health Kit in providing accessible healthcare How the platform partners with enterprises to engage underserved populations The significance of Mark Cuban's Cosplus Pharmacy partnership and its impact on medication affordability The origin story of Sheena Menezes: from Kuwait refugee to healthcare innovator The role of digital and physical channels in delivering health kits and lab testing Vision for the future: bringing high-quality, personalized healthcare to rural and underserved areas The importance of primary care access, especially in rural health settings The influence of technology, including AI and community-focused models, in preventive care Timestamps: 00:00 - Welcome and overview of Simple Health Kit's mission 00:36 - How Simple Health Kit puts individuals at the center of care 01:43 - Major announcement: partnership with Mark Cuban's Cosplus Pharmacy 02:08 - Benefits of the partnership for medication access and affordability 02:53 - Sheena Menezes' inspiring origin story 03:21 - The drive to bring care to those who need it most 03:53 - The growth and scale of Simple Health Kit over seven years 04:16 - How patients can access Simple Health Kit products via health plans, stores, and online 04:45 - Physical in-store health kits and direct-to-consumer options 05:04 - The range of lab testing available: diabetes, kidney, cancer, STI 05:24 - Strategic channels: payers, providers, and pharmacies 05:28 - Vision for universal healthcare access in the next decade 06:03 - Focus on high-level, concierge care in underserved areas 06:32 - Exciting future developments and Mark Cuban connection Resources & Links: https://www.simplehealthkit.com/ Connect with Dr. Sheena Menezes:   / sheenamenezes

    8 min

Ratings & Reviews

4.5
out of 5
8 Ratings

About

Welcome to Boombostic Health, where we challenge the business of healthcare and explore bold ideas that drive meaningful change. Each week we bring you candid conversations with top experts, innovators and leaders exploring the latest trends and technologies shaping the future of healthcare.